SIG Brokerage’s Axsome Therapeutics AXSM Stock Holding History

SIG Brokerage’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-15,000	Closed	-$1.27M	–	550
2024 Q4	$1.27M	Buy	+15,000	New	+$1.38M	0.07%	190

Other funds holding AXSM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

SIG Brokerage's AXSM Position: Q2 2026 in Review

SIG Brokerage sold out of Axsome Therapeutics (AXSM) in Q2 2026, closing a stake of 2,298 shares — an estimated $388K sold.

SIG Brokerage first reported a position in AXSM in Q1 2026 and held it in 1 quarter. The position peaked at $388K in Q1 2026. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

SIG Brokerage reported no remaining Axsome Therapeutics position as of Q2 2026 after selling out during the quarter.
SIG Brokerage sold 2,298 Axsome Therapeutics shares in Q2 2026, an estimated $388K.
SIG Brokerage first reported a position in Axsome Therapeutics in Q1 2026 and held it in 1 quarter.
SIG Brokerage's Axsome Therapeutics position peaked at $388K in Q1 2026.
506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on SIG Brokerage's 13F filing for Q2 2026, filed 14 Aug 2026.